Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis. [electronic resource]
- Advances in therapy
- 208-17 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0741-238X
10.1007/BF02850127 doi
Antirheumatic Agents--administration & dosage Arthritis, Rheumatoid--drug therapy Humans Interleukin 1 Receptor Antagonist Protein Quality of Life Randomized Controlled Trials as Topic Receptors, Interleukin-1--antagonists & inhibitors Recombinant Proteins--administration & dosage Sialoglycoproteins--administration & dosage